| Literature DB >> 35215350 |
Intan Tsamrotul Fu'adah1, Sri Adi Sumiwi1, Gofarana Wilar1.
Abstract
Bouea macrophylla Griffith (B. macrophylla) is one of the many herbal plants found in Asia, and its fruit is plum mango. This plant is rich in secondary metabolites, including flavonoids, tannins, polyphenolic compounds, and many others. Due to its bioactive components, plum mango has powerful antioxidants that have therapeutic benefits for many common ailments, including cardiovascular disease, diabetes, and cancer. This review describes the evolution of plum mango's phytochemical properties and pharmacological activities including in vitro and in vivo studies. The pharmacological activities of B. macrophylla Griffith reviewed in this article are antioxidant, anticancer, antihyperglycemic, antimicrobial, and antiphotoaging. Each of these pharmacological activities described and studied the possible cellular and molecular mechanisms of action. Interestingly, plum mango seeds show good pharmacological activity where the seed is the part of the plant that is a waste product. This can be an advantage because of its economic value as a herbal medicine. Overall, the findings described in this review aim to allow this plant to be explored and utilized more widely, especially as a new drug discovery.Entities:
Keywords: Bouea macrophylla Griffith; anticancer; antihyperglycemic; antimicrobial; antioxidant; antiphotoaging
Year: 2022 PMID: 35215350 PMCID: PMC8880147 DOI: 10.3390/ph15020238
Source DB: PubMed Journal: Pharmaceuticals (Basel) ISSN: 1424-8247
Figure 1Bouea macrophylla Griffith; (A) leaves, (B) fruits, (C) seeds.
Figure 2Chemical structure of gallic acid (A), ethyl gallate (B), and pentagalloyl glucose (C).
Figure 3A summary of the pharmacological activities of B. macrophylla Griffith.
Antioxidant Activity of B. macrophylla Griffith.
| Plant Part | Extraction Technique | Total Phenolic Content | Antioxidant Assay | Antioxidant Activity | Reference | |
|---|---|---|---|---|---|---|
| Seed | Ethanol maceration | 0.77 mg GAE/mg (unripe) | FRAP | 114.98 μg Fe2+E/μg | [ | |
| TEAC | 2.21 μg TE/μg | |||||
| DPPH | 20.87 µg/mL | |||||
| 0.47 mg GAE/mg (ripe) | FRAP | 94.82 μg Fe2+E/μg | ||||
| TEAC | 1.72 μg TE/μg | |||||
| DPPH | 31.14 µg/mL | |||||
| Seed | Chloroform maceration | 686.04 mg GAE/g | DPPH | 4.34 µg/mL | [ | |
| Leaves | Ethanol maceration | 530.85 mg GAE/g | ABTS | 1.37 µg/mL | [ | |
| FIC | 1.70 µg/mL | |||||
| Leaves | Ethanol maceration | 68.53 mg GAE/g | DPPH | 55.83 µg/mL | [ | |
| Leaves | Vacuum Evaporator extraction | 117.836 mg GAE/g | DPPH | 26 µg/mL | [ | |
| Leaves | Ethanol maceration | 20 mg GAE/g | FRAP | 5.62 ± 0.38 mg FeSO4 equivalent/g | [ | |
| Hexane maceration | 30.84 mg GAE/g | 4.5 mg FeSO4 equivalent/g | ||||
| Leaves | Water maceration | 364.56 mg GAE/g | DPPH | 35 µg/mL | [ | |
| Fruit | Ripe | Aqueous maceration | - | DPPH | 83% | [ |
| Unripe | 82% | |||||
| Leaves | 76% | |||||
| Fruit | Water maceration | 372.35 µg GAE/g | FRAP | 133.31 μg TEAC/g | [ | |
| DPPH | 258.17 μg VCEAC/g | |||||
| Fruit | Maceration (methanol, Ethanol, and distilled water) | - | FRAP | 16,290.91 µM Fe(II)/100 g | [ | |
| DPPH | 77.69% | |||||
| ABTS | 99.76% | |||||
Anticancer activity of B. macrophylla Griffith.
| Plants Part | Extraction Techniques | Anticancer Assay | Cell Lines | IC50 | Reference |
|---|---|---|---|---|---|
| Leaves | Ethanol maceration | MTT assay | Vero Cell | 35.808 µg/mL | [ |
| Seed | Ethanol maceration | MTT assay | Doxorubicin-sensitive and resistant leukemic(K562, K562/ADR) and lung cancer (GLC4 and GLC4/ADR) cells | 4–16 µg/mL | [ |
| Seed | Ethanol maceration | MTT assay | MCF-7/IR6 cells | 215.42 nM | [ |
| Seed | Ethanol maceration | MTT assay | MCF cells | 6.94 µg/mL | [ |
| Seed | Ethanol maceration | Mammosphere formation assay | Breast cancer stem cells (CSCs) | [ | |
| Seed | Ethanol maceration | Tumorsphere formation assay, colony formation assay, and apoptosis assay | Head and neck squamous cell carcinoma (HNSCC) | 14.52 µg/mL | [ |
Figure 4Anticancer molecular mechanisms of B. macrophylla Griffith.
Antihyperglycemic activity of B. macrophylla Griffith.
| Plants Part | Extraction Techniques | Antihyperglycemic Assay | Dose/IC50 | Mechanisms of Action | Reference |
|---|---|---|---|---|---|
| Seed | Decoction | α-Glucosidase Inhibitory Assay | 0.55 mg/mL | Delayed glucose absorption in the small intestine | [ |
| Leaves | Water maceration | α-Amylase Inhibitory Assay | 60 µg/mL | Inhibit α-Amylase by forming a complex | [ |
| Fruit | Water maceration | α-Glucosidase Inhibitory Assay | 83.44% | Delayed glucose absorption in the small intestine | [ |
Figure 5Antihyperglycemic mechanisms of B. macrophylla Griffith.
Figure 6Mechanisms of action of B. macrophylla Griffith as an antiphotoaging.